Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2015

01.06.2015

Facilitating survivorship program development for health care providers and administrators

verfasst von: Marcia Grant, Denice Economou, Betty Ferrell, Gwen Uman

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This manuscript will describe institutional changes observed through goal analysis that occurred following a multidisciplinary education project, aimed at preparing health care professionals to meet the needs of the growing numbers of cancer survivors.

Method

Postcourse evaluations consisted of quantitative questionnaires and follow-up on three goals created by each participating team, during the 3-day educational program. Evaluations were performed 6, 12, and 18 months postcourse for percent of goal achievement. Goals were a priori coded based on the Institute of Medicine’s survivorship care components along with two additional codes related to program development and education.

Results

Two hundred and four teams participated over the four yearly courses. A total of 51.6 % of goals were related to program development, 21 % to survivorship care interventions, 20.9 % on educational goals, and only 4.7 % related to coordination of care, 1.4 % on surveillance, and 0.4 % related to prevention-focused goals. Quantitative measures postcourse showed significant changes in comfort and effectiveness in survivorship care in the participating institutions.

Conclusion

During the period 2006–2009, health care institutions focused on developing survivorship care programs and educating staff, in an effort to prepare colleagues to provide and coordinate survivorship care, in cancer settings across the country.

Implications for cancer survivors

Goal-directed education provided insight into survivorship activities occurring across the nation. Researchers were able to identify survivorship care programs and activities, as well as the barriers to developing these programs. This presented opportunities to discuss possible interventions to improve follow-up care and survivors’ quality of life.
Literatur
3.
Zurück zum Zitat Institute of Medicine [IOM], From cancer patient to cancer survivor: lost in transition, M. Hewitt, S. Greenfield, and E. Stovall, Editors. 2006, The National Academies Press: Washington DC. p. 9–186 Institute of Medicine [IOM], From cancer patient to cancer survivor: lost in transition, M. Hewitt, S. Greenfield, and E. Stovall, Editors. 2006, The National Academies Press: Washington DC. p. 9–186
4.
Zurück zum Zitat Brearley SG et al. The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature. Eur J Oncol Nurs. 2011;15(3):204–12.CrossRefPubMed Brearley SG et al. The physical and practical problems experienced by cancer survivors: a rapid review and synthesis of the literature. Eur J Oncol Nurs. 2011;15(3):204–12.CrossRefPubMed
5.
Zurück zum Zitat Ness S et al. Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum. 2013;40(1):35–42.CrossRefPubMed Ness S et al. Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum. 2013;40(1):35–42.CrossRefPubMed
6.
Zurück zum Zitat Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51.CrossRefPubMed Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51.CrossRefPubMed
7.
Zurück zum Zitat McCabe MS et al. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631–40.CrossRefPubMed McCabe MS et al. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631–40.CrossRefPubMed
8.
Zurück zum Zitat Krugman M, Smith K, Goode CJ. A clinical advancement program: evaluating 10 years of progressive change. J Nurs Adm. 2000;30(5):215–25.CrossRefPubMed Krugman M, Smith K, Goode CJ. A clinical advancement program: evaluating 10 years of progressive change. J Nurs Adm. 2000;30(5):215–25.CrossRefPubMed
9.
Zurück zum Zitat Lester JL, Wessels AL, Jung Y. Oncology nurses’ knowledge of survivorship care planning: the need for education. Oncol Nurs Forum. 2014;41(2):E35–43.CrossRefPubMed Lester JL, Wessels AL, Jung Y. Oncology nurses’ knowledge of survivorship care planning: the need for education. Oncol Nurs Forum. 2014;41(2):E35–43.CrossRefPubMed
10.
Zurück zum Zitat Ferris FD, von Gunten CF, Emanuel LL. Knowledge: insufficient for change. J Palliat Med. 2001;4(2):145–7.CrossRefPubMed Ferris FD, von Gunten CF, Emanuel LL. Knowledge: insufficient for change. J Palliat Med. 2001;4(2):145–7.CrossRefPubMed
11.
Zurück zum Zitat Grant M et al. Educating health care professionals to provide institutional changes in cancer survivorship care. J Cancer Educ. 2012;27(2):226–32.PubMedCentralCrossRefPubMed Grant M et al. Educating health care professionals to provide institutional changes in cancer survivorship care. J Cancer Educ. 2012;27(2):226–32.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4(6):523–31.CrossRefPubMed Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4(6):523–31.CrossRefPubMed
13.
Zurück zum Zitat Knowles, M.S. The adult learner: a neglected species. Vol. 4e. Houston: Gulf Publishing; 1973, 1990. Knowles, M.S. The adult learner: a neglected species. Vol. 4e. Houston: Gulf Publishing; 1973, 1990.
14.
Zurück zum Zitat O’Neill J, Conzemius A, Commodore C, Pulsfus C. The Power of SMART goals—using goals to improve student learning. Bloomington: Solution Tree Press; 2006. O’Neill J, Conzemius A, Commodore C, Pulsfus C. The Power of SMART goals—using goals to improve student learning. Bloomington: Solution Tree Press; 2006.
15.
Zurück zum Zitat Gates P, Krishnasamy M. Nurse-led survivorship care. Cancer Forum. 2009;33(3):176–9. Gates P, Krishnasamy M. Nurse-led survivorship care. Cancer Forum. 2009;33(3):176–9.
16.
Zurück zum Zitat Needleman J et al. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med. 2002;346(22):1715–22.CrossRefPubMed Needleman J et al. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med. 2002;346(22):1715–22.CrossRefPubMed
18.
Zurück zum Zitat McCabe MS, Jacobs L. Survivorship care: models and programs. Semin Oncol Nurs. 2008;24(3):202–7.CrossRefPubMed McCabe MS, Jacobs L. Survivorship care: models and programs. Semin Oncol Nurs. 2008;24(3):202–7.CrossRefPubMed
20.
Zurück zum Zitat ASCO, Clincal Practice Guidelines: Practice Resources ASCO, Clincal Practice Guidelines: Practice Resources
21.
Zurück zum Zitat Wyatt DE. The impact of oncology education on practice—a literature review. Eur J Oncol Nurs. 2007;11(3):255–61.CrossRefPubMed Wyatt DE. The impact of oncology education on practice—a literature review. Eur J Oncol Nurs. 2007;11(3):255–61.CrossRefPubMed
22.
Zurück zum Zitat McCabe, M.S., et al.. American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31:631–40 McCabe, M.S., et al.. American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31:631–40
Metadaten
Titel
Facilitating survivorship program development for health care providers and administrators
verfasst von
Marcia Grant
Denice Economou
Betty Ferrell
Gwen Uman
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2015
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0397-8

Weitere Artikel der Ausgabe 2/2015

Journal of Cancer Survivorship 2/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.